We are live on
!
Find out more
OA
Oak Associates Portfolio holdings
AUM
$1.49B
1-Year Est. Return
34.25%
This Fund
S&P 500
This Quarter
Est. Return
-17.24%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.28B
AUM Growth
-$359M
(-22%)
Cap. Flow
-$60.5M
Cap. Flow
% of AUM
-4.73%
Top 10 Holdings %
Top 10 Hldgs %
43.57%
Holding
141
New
3
Increased
11
Reduced
53
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$1.34M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
+$1.33M |
| 3 |
Pfizer
PFE
|
+$762K |
| 4 |
PayPal
PYPL
|
+$467K |
| 5 |
Medpace
MEDP
|
+$463K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$7.62M |
| 2 |
DraftKings
DKNG
|
+$5.16M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$4.7M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.88M |
| 5 |
eBay
EBAY
|
+$3.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.48% |
| 2 | Healthcare | 16.66% |
| 3 | Communication Services | 14.06% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Financials | 11.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Thor Industries
THO
$3.98B
| $261K | 0.02% |
3,490
| – | – |
|
127
Viatris
VTRS
$20.5B
| $213K | 0.02% |
20,321
-31,653
| -61% | -$347K |
|
128
Murphy USA
MUSA
$11.3B
| $201K | 0.02% |
+864
| New | +$204K |
|
129
American Public Education
APEI
$907M
| – | – |
-22,319
| Closed | -$474K |
|
130
Cognyte Software
CGNT
$642M
| – | – |
-57,724
| Closed | -$653K |
|
|
131
DraftKings
DKNG
$12B
| – | – |
-265,193
| Closed | -$5.16M |
|
|
EB
132
DELISTED
Eventbrite
EB
| – | – |
-29,882
| Closed | -$441K |
|
133
Enovis
ENOV
$1.63B
| – | – |
-6,307
| Closed | -$432K |
|
134
Neurocrine Biosciences
NBIX
$17.7B
| – | – |
-16,361
| Closed | -$1.53M |
|
135
Palo Alto Networks
PANW
$259B
| – | – |
-24,780
| Closed | -$2.57M |
|
136
PROG Holdings
PRG
$1.73B
| – | – |
-9,795
| Closed | -$282K |
|
137
QuinStreet
QNST
$893M
| – | – |
-18,980
| Closed | -$220K |
|
138
LiveRamp
RAMP
$2.3B
| – | – |
-12,615
| Closed | -$472K |
|
139
TD Synnex
SNX
$19.6B
| – | – |
-4,000
| Closed | -$413K |
|
|
ZIMV
140
DELISTED
ZimVie
ZIMV
| – | – |
-10,616
| Closed | -$242K |
|
Similar funds
FAT
AIA
LFS
PIM
NAM
RIM
SB
MHS
Oak Associates's Q2 2022 Portfolio in Review
As of Q2 2022, Oak Associates held 141 positions worth $1.28B, down 22% from $1.64B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Oak Associates withdrew a net $60.5M in Q2 2022, closing 12 positions and reducing 53 holdings. Its most notable exit was DraftKings, an estimated $5.16M position sold in full.
By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 42% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Oak Associates opened a new position in Moderna worth $1.34M.
- Oak Associates's largest Q2 2022 buy was Moderna: 9,393 shares worth $1.34M.
- Oak Associates added most to Pfizer in Q2 2022, an estimated $762K increase.
- Oak Associates's biggest Q2 2022 reduction was Apple, cutting an estimated $7.62M.
- Oak Associates fully exited DraftKings in Q2 2022, selling an estimated $5.16M.
- Oak Associates's ten largest holdings make up 44% of its $1.28B portfolio in Q2 2022.
- Oak Associates opened 3 new positions and closed 12 in Q2 2022.
- Oak Associates's portfolio value fell 22% quarter-over-quarter to $1.28B.
Based on Oak Associates's 13F filing for Q2 2022, filed 12 Aug 2022.